Neodymium Magnetic Bead Ingestion in a Toddler

Por Hui, Kenneth J., Arasu, Vignesh A., Vinson, David R., Cotton, Dale M.
Publicado no Perm J (2020)

Diagnostic Emergency Imaging Utilization at an Academic Trauma Center From 1996 to 2012

Por Arasu, Vignesh A., Abujudeh, Hani H., Biddinger, Paul D., Noble, Vicki E., Halpern, Elkan F., Thrall, James H., Novelline, Robert A.
Publicado no J Am Coll Radiol (2015)

Can Signal Enhancement Ratio (SER) Reduce the Number of Recommended Biopsies without Affecting Cancer Yield in Occult MRI-detected Lesions?

Por Arasu, Vignesh A., Chen, Ryan C-Y., Newitt, David N., Chang, C. Belinda, Tso, Hilda, Hylton, Nola M., Joe, Bonnie N.
Publicado no Acad Radiol (2011)

Effect of Background Parenchymal Enhancement on Breast MR Imaging Interpretive Performance in Community-based Practices

Por Ray, Kimberly M., Kerlikowske, Karla, Lobach, Iryna V., Hofmann, Michael B., Greenwood, Heather I., Arasu, Vignesh A., Hylton, Nola M., Joe, Bonnie N.
Publicado no Radiology (2018)

Benefit of Semiannual Ipsilateral Mammographic Surveillance Following Breast Conservation Therapy

Por Arasu, Vignesh A., Joe, Bonnie N., Lvoff, Natalya M., Leung, Jessica W.T., Brenner, R. James, Flowers, Chris I., Moore, Dan H., Sickles, Edward A.
Publicado em 2012

Effect of MR Imaging Contrast Thresholds on Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes: A Subgroup Analysis of the ACRIN 6657/I-SPY 1 TRIAL

Por Li, Wen, Arasu, Vignesh, Newitt, David C., Jones, Ella F., Wilmes, Lisa, Gibbs, Jessica, Kornak, John, Joe, Bonnie N., Esserman, Laura J., Hylton, Nola M.
Publicado no Tomography (2016)

Impact of MRI Protocol Adherence on Prediction of Pathological Complete Response in the I-SPY 2 Neoadjuvant Breast Cancer Trial

Por Onishi, Natsuko, Li, Wen, Gibbs, Jessica, Wilmes, Lisa J., Nguyen, Alex, Jones, Ella F., Arasu, Vignesh, Kornak, John, Joe, Bonnie N., Esserman, Laura J., Newitt, David C., Hylton, Nola M.
Publicado no Tomography (2020)

Comparison of Segmentation Methods in Assessing Background Parenchymal Enhancement as a Biomarker for Response to Neoadjuvant Therapy

Por Nguyen, Alex Anh-Tu, Arasu, Vignesh A., Strand, Fredrik, Li, Wen, Onishi, Natsuko, Gibbs, Jessica, Jones, Ella F., Joe, Bonnie N., Esserman, Laura J., Newitt, David C., Hylton, Nola M.
Publicado no Tomography (2020)

Additive value of diffusion weighted MRI in the I-SPY 2 TRIAL

Por Li, Wen, Newitt, David C., Wilmes, Lisa J., Jones, Ella F., Arasu, Vignesh, Gibbs, Jessica, Yun, Bo La, Li, Elizabeth, Partridge, Savannah C., Kornak, John, Esserman, Laura J., Hylton, Nola M.
Publicado no J Magn Reson Imaging (2019)

Predictive Value of Breast MRI Background Parenchymal Enhancement for Neoadjuvant Treatment Response among HER2− Patients

Por Arasu, Vignesh A, Kim, Paul, Li, Wen, Strand, Fredrik, McHargue, Cody, Harnish, Roy, Newitt, David C, Jones, Ella F, Glymour, M Maria, Kornak, John, Esserman, Laura J, Hylton, Nola M
Publicado no J Breast Imaging (2020)

Tumor Sphericity Predicts Response in Neoadjuvant Chemotherapy for Invasive Breast Cancer

Por Li, Wen, Newitt, David C., Yun, Bo La, Jones, Ella F., Arasu, Vignesh, Wilmes, Lisa J., Gibbs, Jessica, Nguyen, Alex Anh-Tu, Onishi, Natsuko, Kornak, John, Joe, Bonnie N., Esserman, Laura J., Hylton, Nola M.
Publicado no Tomography (2020)

Exploration of PET and MRI radiomic features for decoding breast cancer phenotypes and prognosis

Por Huang, Shih-ying, Franc, Benjamin L., Harnish, Roy J., Liu, Gengbo, Mitra, Debasis, Copeland, Timothy P., Arasu, Vignesh A., Kornak, John, Jones, Ella F., Behr, Spencer C., Hylton, Nola M., Price, Elissa R., Esserman, Laura, Seo, Youngho
Publicado no NPJ Breast Cancer (2018)

Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk

Por Arasu, Vignesh A., Miglioretti, Diana L., Sprague, Brian L., Alsheik, Nila H., Buist, Diana S.M., Henderson, Louise M., Herschorn, Sally D., Lee, Janie M., Onega, Tracy, Rauscher, Garth H., Wernli, Karen J., Lehman, Constance D., Kerlikowske, Karla
Publicado no J Clin Oncol (2019)

Predicting breast cancer response to neoadjuvant treatment using multi-feature MRI: results from the I-SPY 2 TRIAL

Por Li, Wen, Newitt, David C., Gibbs, Jessica, Wilmes, Lisa J., Jones, Ella F., Arasu, Vignesh A., Strand, Fredrik, Onishi, Natsuko, Nguyen, Alex Anh-Tu, Kornak, John, Joe, Bonnie N., Price, Elissa R., Ojeda-Fournier, Haydee, Eghtedari, Mohammad, Zamora, Kathryn W., Woodard, Stefanie A., Umphrey, Heidi, Bernreuter, Wanda, Nelson, Michael, Church, An Ly, Bolan, Patrick, Kuritza, Theresa, Ward, Kathleen, Morley, Kevin, Wolverton, Dulcy, Fountain, Kelly, Lopez-Paniagua, Dan, Hardesty, Lara, Brandt, Kathy, McDonald, Elizabeth S., Rosen, Mark, Kontos, Despina, Abe, Hiroyuki, Sheth, Deepa, Crane, Erin P., Dillis, Charlotte, Sheth, Pulin, Hovanessian-Larsen, Linda, Bang, Dae Hee, Porter, Bruce, Oh, Karen Y., Jafarian, Neda, Tudorica, Alina, Niell, Bethany L., Drukteinis, Jennifer, Newell, Mary S., Cohen, Michael A., Giurescu, Marina, Berman, Elise, Lehman, Constance, Partridge, Savannah C., Fitzpatrick, Kimberly A., Borders, Marisa H., Yang, Wei T., Dogan, Basak, Goudreau, Sally, Chenevert, Thomas, Yau, Christina, DeMichele, Angela, Berry, Don, Esserman, Laura J., Hylton, Nola M.
Publicado no NPJ Breast Cancer (2020)